Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Bekeken
• 08/04/23
0
0
insluiten
administrator
abonnees
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties